Other
Vitamin D3
0
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Vitamin D3 is an early-stage landscape with 0 programs across 1 company. The most active players are Takeda.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
26
clinical trials
Completed19 · 73%
Unknown status3 · 12%
Terminated2 · 8%
Recruiting1 · 4%
Withdrawn1 · 4%
Clinical Trials
Trial Activity
26 trials
Assessment of the Locally Administrated Vitamin D3 and Corticision Efficacy on Orthodontic Canine Retraction
Recruiting·—·N/A·NCT07455656·16 enrolled
Study of MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (MK-0217A-329)
Completed·—·Phase 3·NCT01437111·200 enrolled
Safety and Pharmacokinetic Characteristics of DP-R206(Vitamin D3) in Healthy Adult Volunteers
Completed·—·Phase 1·NCT01577849·36 enrolled
Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients
Completed·—·Phase 1·NCT03781895·48 enrolled
Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome
Completed·—·Phase 3·NCT01817166·316 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)